Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
09/08/2006 | CA2579888A1 Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
09/07/2006 | US20060199168 Cell recovery |
09/07/2006 | US20060198939 Porous ceramic composite bone grafts |
09/07/2006 | US20060198900 Bioactive Agent Compositions for Repair of Cell Injuries |
09/07/2006 | US20060198899 Supplemental dietary composition for supporting muscle growth, recovery and strength |
09/07/2006 | US20060198898 Orally administering edible oil homogenized with an edible wax at a concentration ranging from 0.5% to 50% by weight and a sterol compound at a concentration of at least 0.1% by weight for repairing and promoting regeneration of mucosa in the GI tract |
09/07/2006 | US20060198831 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
09/07/2006 | US20060198827 Engineering vascularized muscle tissue |
09/07/2006 | US20060198826 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
09/07/2006 | US20060198822 Treatment for multiple sclerosis |
09/07/2006 | US20060196833 Method for isolating hepatocytes |
09/07/2006 | DE10038700B4 Autologe Bindegewebe, Verfahren zu ihrer Herstellung und ihre Verwendung Autologous connective tissue, processes for their preparation and their use |
09/06/2006 | EP1698356A1 Decellularized tissue and method of preparing the same |
09/06/2006 | EP1698320A1 Skin moisturizing agent for oral intake and functional foods and drinks |
09/06/2006 | EP1697522A2 Plasmid maintenance |
09/06/2006 | EP1697521A2 Multi plasmid system for the production of influenza virus |
09/06/2006 | EP1697506A1 Method for isolating cells from mammary secretion |
09/06/2006 | EP1697503A2 Cell culture with nm23, cell culture media comprising nm23 and therapeutic use of cells cultured in the presence of nm23 |
09/06/2006 | EP1697502A2 Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and uses thereof |
09/06/2006 | EP1697500A1 Stem cells |
09/06/2006 | EP1696941A1 Lactic acid producing bacteria and lung function |
09/06/2006 | EP1696940A1 A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma |
09/06/2006 | EP1696735A1 Anti-diarrhea composition containing glutamine |
09/06/2006 | EP1539928A4 Cd56 positive human adult pancreatic endocrine progenitor cells |
09/06/2006 | EP1444328A4 Induction of beta cell differentiation in human cells |
09/06/2006 | EP1341517B1 A skin cream composition |
09/06/2006 | EP1286652B1 Skin protectant spray compositions |
09/06/2006 | EP1204418B1 Compositions containing muscle-derived active agents |
09/06/2006 | EP1176964B1 Uses of et743 for treating cancer |
09/06/2006 | EP1127149B1 Cells for the production of helper dependent adenoviral vectors |
09/06/2006 | EP1023435B1 Novel lactic acid bacteria species |
09/06/2006 | EP0815204B1 Method for treating tumors by alloactivated human donor lymphocytes |
09/06/2006 | EP0781137B1 Use of phosphoglycerides comprising phosphoglycero ethers for treating neurodegenerative diseases in mentally severe handicapped children |
09/06/2006 | CN1829797A Compositions and methods for preventing and treating liver cirrhosis |
09/06/2006 | CN1829791A 皮肤再生系统 Skin Regeneration System |
09/06/2006 | CN1829530A Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds |
09/06/2006 | CN1829523A Viral vectors |
09/06/2006 | CN1829452A Infant or follow-on formula |
09/06/2006 | CN1827766A In vitro cell cultivation method |
09/06/2006 | CN1827159A Menstruation-regulating preparation and novel method for preparing the same |
09/06/2006 | CN1827150A Externally applied emulsion film for treating rheumatic and rheumatoid disease and its preparing method |
09/06/2006 | CN1827140A Chinese medicinal pill for treating cancer |
09/06/2006 | CN1827137A Blood-activating bone-resetting capsule |
09/06/2006 | CN1827136A Compound Chinese medicinal preparation for treating male sterility |
09/06/2006 | CN1827133A Medicine for treating dermatopathy and its preparing process |
09/06/2006 | CN1827123A Chinese traditional medicine for treating osteoporosis |
09/06/2006 | CN1827067A Bag with Chinese medicine and stone grains for hot compression therapy |
09/06/2006 | CN1827063A Method for producing bilirubin by inputting exogenous blood to biliary drainage pig |
09/06/2006 | CN1826974A Health seasoning |
09/06/2006 | CN1826954A Health-caring vermicelli with fresh-water turtle shell |
09/06/2006 | CN1273507C Coating material for leukocyte removal filter and the filter material |
09/06/2006 | CN1273184C Formulation of analgecizing and bone strengthening adhesive plaster and its manufacturing process |
09/06/2006 | CN1273178C Chinese medicine composition for treating rheumatoid arthritis |
09/06/2006 | CN1273177C Chinese medicinal capsule for treating nephropathy and its production method |
09/06/2006 | CN1273172C Medicine for treating chronic colonitis |
09/06/2006 | CN1273164C Cough-stopping tablet and its preparation method |
09/06/2006 | CN1273049C Health-care food and preparation method thereof |
09/05/2006 | US7101846 Methods and compositions for optimization of oxygen transport by cell-free systems |
09/05/2006 | US7101711 Activating a T gamma 9 delta 2 lymphocyte at a minimum activation concentration of below 100 nM, in vitro by contacting with a 3,4-epoxy-3-methyl-1-butyl diphosphate substituted with a biomolecule |
09/05/2006 | US7101709 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator |
09/05/2006 | US7101708 Hematopoietic cell composition for use in transplantation |
09/05/2006 | US7101705 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
09/05/2006 | US7101704 Expressing a co-stimulatory molecule, treated with interferon- gamma, and modified to have an exogenous antigen fragment bound to MHCII; antigen is presented to initiate an immune response |
09/05/2006 | US7101565 Probiotic/prebiotic composition and delivery method |
09/05/2006 | US7101555 Microorganismal polypeptides for use in diagnosis and treatment of respiratory system disorders; genetic vaccines |
09/05/2006 | US7101546 Encapsulating a cell culture of propagating pancreatic cells; inserting the encapsulated cells into the mammal permitting the cells to mature to insulin secreting cells |
09/05/2006 | US7101545 culturing minced human intervertebral cells to form a monolayer, isolating the disc cells from monolayer, dispersing the cells in a carrier, implanting carrier/cells into a target disc area; propagating disc cells in vitro |
09/02/2006 | CA2513350A1 Treatment for multiple sclerosis |
08/31/2006 | WO2006091804A2 Compositions and methods for the treatment of acne |
08/31/2006 | WO2006091546A2 Use of amniotic fluid (af) in treating ocular disease and injury |
08/31/2006 | WO2006091038A1 Pharmaceutical composition for treating avellino cornea dystrophy comprising blood plasma or serum |
08/31/2006 | WO2006090910A1 Novel steroid glycoside, ngf-associated active substance, process for producing the same, method of screening thereof, and cerebral dysfunction preventive agent |
08/31/2006 | WO2006090906A1 NOVEL METHOD FOR OVERCOMING RNAi-RESISTANT STRAIN OF VIRUS |
08/31/2006 | WO2006090882A1 Method for amplification of endothelial progenitor cell in vitro |
08/31/2006 | WO2006090729A1 Fermented tea beverage and tea beverage |
08/31/2006 | WO2006090697A1 Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing pedf and fgf2 |
08/31/2006 | WO2005038430A3 Viral fibers |
08/31/2006 | US20060194731 Using tumor antigens to elicit immune response targeted to cancer cells; immunotherapy |
08/31/2006 | US20060194316 Stromal differentiated neuron-like cells for use in treatment of neurodegenerative, ischemic, spinal cord and ataxic disorders; tissue engineering; regenerative medicine |
08/31/2006 | US20060194293 Rb1 gene induced protein (rb1cc1) and gene |
08/31/2006 | US20060193922 Compositions and methods for the treatment of acne |
08/31/2006 | US20060193875 Method of treating human-immunodeficiency virus (hiv) disease infection |
08/31/2006 | US20060193872 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
08/31/2006 | US20060193871 transmission and, or amplification of signal; oral or enteric administering, dissolving, absorption; peptide yy; obesity therapy |
08/31/2006 | US20060193852 immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma; single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen; domains are arranged in the order VLCD19-VHCD19-VHCD3-VLCD3; vector; cell |
08/31/2006 | US20060193847 Peptides for inhibiting retroviruses |
08/31/2006 | US20060193842 Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life |
08/31/2006 | US20060193840 Perivascular mesenchymal precursor cell induced blood vessel formation |
08/31/2006 | US20060193839 Time varying electromagnetic force ("TVEMF") expanded blood stem cells from a mammal, used for repair of tissues |
08/31/2006 | US20060193838 Method and composition for treating diabetes |
08/31/2006 | US20060193837 Method and composition for repairing epithelial and other cells and tissue |
08/31/2006 | US20060193836 Method and composition for repairing heart tissue |
08/31/2006 | US20060193835 Treatment of congestive heart failure |
08/31/2006 | US20060193834 Antiprotozal composition |
08/31/2006 | US20060193833 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
08/31/2006 | DE10335845B4 Pheromone als Antikrebsmittel Pheromones as anticancer agents |
08/31/2006 | CA2596794A1 Tea-based fermentation beverage and tea beverage |
08/30/2006 | EP1696036A1 Use of recombinant adeno-associated virus in the manufacture of a medicament for gene therapy via muscle cells |
08/30/2006 | EP1696028A2 Compositions and methods for the therapy and diagnosis of breast cancer |
08/30/2006 | EP1696027A1 Hla-dr-binding antigen peptide derived from wt1 |